MetaCap

Madrigal Pharmaceuticals Statistics

NASDAQ: MDGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

379.10-17.64 (-4.45%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Madrigal Pharmaceuticals by the numbers

Madrigal Pharmaceuticals has a market capitalization of $8.81 billion based on 23.23M shares outstanding. With trailing EPS of $-5.85, Madrigal Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.0% below its 50-day average and 23.3% below its 200-day average.

Average daily trading volume is 370.07K shares, or about $140.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MDGL valuation vs. peer median

MDGL compared with the median of 8 peer companies
MetricMDGLPeer medianDifference
Market cap$8.81B$7.94B+11%
Forward P/E36.539.6-8%
Avg. volume370.07K1.18M-69%

Peer median across 8 companies: SYRE, PRAX, TGTX, SMMT, PTGX, RYTM, ALKS, KNSA.

Valuation

Price / sales (latest FY)
9.19
EPS (TTM)
$-5.85

Price and trading

Previous close
396.74
Open
396.21
Day range
377.91 – 399.43
52-week range
353.54 – 615.00
52-week change
-30.82%
Beta
—
Volume
327.83K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
8.81B
Forward Pe
36.52
Eps
-5.85
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
615.00
Week52 Low
353.54
Avg Volume
370.07K
Shares Outstanding
23.23M
Ma50
462.33
Ma200
494.08
Earnings Date
Nov 3, 2026
Pct From52w High
-38.36%
Pct From52w Low
7.23%

Related